RESUME Titre: La prise en charge du pied diabétique aux urgences
Annexe 2 Tableau 33 : Classification de PEDIS du pied diabétique [42]
Prise en charge du pied diabétique aux urgences
115 Bibliographie
Prise en charge du pied diabétique aux urgences
116
1. Charles Pierret, J.-P.T., Lise Bordier , Emmanuel Blin , Vincent Duverger , La
revascularisation du pied diabétique Presse Med. 2011; 40: 10–16.
2. Fontbonne, A., Épidémiologie des états diabétiques Diabétologie 2014.
3. J.E. SHAW, R.A.S., P.Z. Zimmet, Global estimates of the prevalence of diabetes for 2010 and
2030. diabetes reseach and clinical practice 87 (2010) 4 – 1 4, 2009.
4. Recommandations de Bonnes Pratiques Médicales. Affection Longue Durée ALD 6 (Selon
l’Arrêté Ministériel) Diabète de type 2page:11, Mars 2013.
5. CavanaghPR , L.B., Bradbury AW, Botek G., Treatment for diabetic foot ulcers. Lancet. 2005
Nov 12;366(9498):1725-35.
6. VAN, G.H., chapitre 11 :infection du pied diabétique,Le pied diabétique édition 2008 page 129 7. Boutoille D, F.A., Maulaz D, Krempf M., Quality of life with diabetes-associated foot
complications:comparison between lower-limb amputation and chronic foot ulceration. Foot Ankle Int 2008;29:1074—8.
8. Carrington A, M.S., Morley M, Kincey J, Boulton AJM. , Psychological status of diabetic
people with or without lower limb disability. Diabetes Res Clin Pract 1996; 32: 19- 25.
9. Apelqvist J, L.J., Agardh CD., Long-term prognosis for diabetic patients with foot ulcers. J
Intern Med 1993; 233: 485-91.
10. Lutter LD, M.M., Pfeffer GB, editors. , Hecht PJ, Lee TH. The insensitive foot (diabetic foot).
Orthopaedic knowledge update: foot and ankle.
11. Fagot-Campagna A, F.S., Roudier.C, Romon.T, Penformis.A, lecompte.P, etal.,
Caractéristiques, risque vasculaire et complications chez les personnes diabétiques en France métropolitaine : d'importantes évolutions entre Entred 2001 et Entred 2007. Numéro thématique. Les enquêtes Entred : des outils épidémiologiques et d'évaluation pour mieux comprendre et maîtriser le diabète / Fagot Campagna A in Bulletin Epidémiologique Hebdomadaire [Bull Epidemiol Hebd], N° 42-43 (10/11/2009)
12. Walters DP, G.W., Mullee MA, Hill RD. , The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group. Diabet Med 9:354-358, 1992.
13. Kumar S, A.H., Parnell LN, Fernando DJ, Tsigos C, Young and W.J. RJ, Boulton AJ. , The
prevalence of foot ulceration and its correlates in type 2 diabetic patients: a population-based study. Diabetic Med 11:480-484, 1994.
Prise en charge du pied diabétique aux urgences
117
14. Most RS, S.P., The Epidemiology of Lower Extremity Amputations in Diabetic Individuals.
Diabetics Care 1983; 6:87-91.
15. Feron, F., et al., P108 Prise en charge des plaies de pied du patient diabétique en médecine
générale : place de la décharge. Diabetes & Metabolism, 2014. 40: p. A55.
16. Fatima., N., Pied diabétique : actualités et perspectives (à propos de 90 cas).Thèse de
doctorat en médecine, n°5, Rabat, 2006.
17. Lamchahab, F.Z., et al., Factors influencing the awareness of diabetic foot risks. Ann Phys Rehabil Med, 2011. 54(6): p. 359-65.
18. I. Yassine, F.A., K. Lahlou, Evaluation des connaissances des patients sur le pied diabétique,
CHU Hassan II , Fès,Maroc2015.
19. K. Bertal Filali, A.E., A. Diouri, Profil clinique, bactériologique et thérapeutique de l'infection
du pied diabétique. A propos de 31 cas. Endocrinologie Diabétologie Nutrition, CHU, Marrakech, Maroc 2009
20. Lipsky BA, B.A., Principles and practice of antibiotic therapy of diabetic foot infections.
Diabetes Metab Res Rev 2000;16:S42-6.
21. Contact osseux,
http://www.antimicrobe.org/images-Monographs/e26_InfectedUlcerAfterDebridementProbed.jpg.
22. D. Amoussou-Guenou, E.B., A. Wanvoegbe, J. Segnon-Agueh, F. Djorolo, A. Kerekou,
Bactériologie des plaies du diabétique à Cotounou. SFE Paris 2013/ Annales d'Endocrinologie
74 (2013) 387-419.
23. Yan J , L.Y., Zhou B, Sun M., Pre-hospital delay in patients with diabetic foot problems:
influencing factors and subsequent quality of care. Diabet Med. 2014 May;31(5):624-9. Epub 2014 Jan 17.
24. M. Gourine, M.M., M. Arrar, Pied diabétique une complication qui en cache souvent d'autres
CHU OURANSFD 2013Service de médecine Interne CHU, Oran, Algérie.
25. H. Ibrahim , N.T., N. Fendri , A. Loukil , A. Trimeche, Études des facteurs de risque des lésions
du pied chez lediabétique. SFE Toulouse 2012 / Annales d’Endocrinologie 73 (2012) 386–411.
26. Fejfarová V, J.A., Dragomirecká E, Game F, Bém R, Dubský M, Wosková V, Křížová M, Skibová J, Wu S., Does the diabetic foot have a significant impact on selected psychological
or social characteristics of patients with diabetes mellitus? J Diabetes Res.
Prise en charge du pied diabétique aux urgences
118
27. A.S. Baldé, N.M.B., T.O. Barry, M.M. Bah, A. Camara, A. Bah, and I.C. S. Bah, M.C. Diallo, M.A. Barry. , Fréquence et caractéristiques cliniques des sujets ayant une lésion du pied
diabétique au CHU de Donka et l’unité de diabétologie de Labé Hôpital Universitaire (Guinée-Conakry).
28. M. Gourine, M.M., M. Arrar, Pied diabetique : une complication qui en cache souvent
d’autres Service de médecine Interne CHU, Oran, Algérie. Diabetes Metab 2013, 39,
A106-A121.
29. K. Faraoun, L.B., F. Tahar-Abbas, K. Sahnine, I. Fazaz, and Z.B. T. Benkhelifa, Pied diabétique
: caractéristiques cliniques et prise en charge au CHU d’Oran SDF 2013.
30. A. Sotto, O.C., S. Schuldiner, N. Bouziges, JL. Richard, JP. Lavigne and SMIT, Évolution de
l’écologie bactérienne des plaies de pied chez les patients diabétiques : étude prospective 2003- 2007 CHU Carémeau, 30029 Nîmes, France.
31. I. Yassine, F.A., K. Lahlou, F. Ajdi, Évaluation des connaissances des patients diabétiques sur
le pied diabétique. CHU Hassan-II, Fès, Maroc.
32. Benjamin A. Lipsky, A.R.B., Paul B. Cornia, James C. Pile, Edgar J. G. Peters, David G. Armstrong,et col., 2012 Infectious Diseases Society of America Clinical Practice Guideline for
the Diagnosis and Treatment of Diabetic Foot Infections. IDSA GUIDELINES, 2012: p.
e140-e164.
33. I., G., Sur la nécessité d'une approche multidisciplinaire du pied diabétique. J Mal Vasc
2001;26:130-4.
34. Hartemann-Heurtier A, H.V.G., Danan JP, et al. , Outcome of severe diabetic foot ulcers after
standardised management in a specialised unit. Diabetes Metab 2002;28:477-84.
35. Lipsky BA, B.A., Deery HG, Embil JM, Karchmer AW, LeFrock JL, and M.J. Lew DP, Norden C, Tan JS. , Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39:885–910. 36. Crane M, W.B., Critical pathway approach to diabetic pedal infections in a multidisciplinary
setting. J Foot Ankle Surg 1999;38:30-3. discussion 82–3.
37. Sumpio BE, A.J., Blume PA. , The multidisciplinary approach to limb salvage. Acta Chir Belg
2004;104:647-53.
38. Apelqvist J, L.J., What is the most effective way to reduce incidence of amputation in the
diabetic foot? Diabetes Metab Res Rev 2000;16:S75- 83.
Prise en charge du pied diabétique aux urgences
119
40. BE., S., Foot ulcers. N Engl J Med 2000;343:787-93.
41. F., G., Management of the diabetic foot: surgical and organisational aspects. Horm Metab
Res 2005;37:69-75.
42. J.-L. Bessea, T.L., P.-A. Deleu . Le pied diabétique : place de la chirurgie orthopédique. Revue
de chirurgie orthopédique et traumatologique (2011) 97, 302-319, Acceptation définitive le : 28 Février 2011.
43. International Working Group on the Diabetic Foot. International consensus on the diabetic foot [CD-ROM]. 2003. In: International Diabetes Foundation; Brussels. http://www.iwgdf.org.
44. Frykberg RG, V.A., Diabetic foot infections. Diabetes Metab Rev 1996;12:255-70.
45. Apelqvist J, B.K., van Houtum WH, Nabuurs-Franssen MH, Schaper and NC., International
consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2000;16:S84-92.
46. Norgren L, H.W., Dormandy JA, Nehler MR, Harris KA, Fowkes FG, , On behalf of the TASC II
Working Group, International-Society Consensus for the managment ofperipheral arterial disease(TASCII). Eur J vasc Endovasc 2007, 33 (Suppl 1):S1 : S75.
47. Kallio M, F.C.G.P., Groop L, Lepäntelo M. , Developpment of a newperipheral arterial
occlusive disease in patients with type 2 diabetes during amean follow-up for 11 years . Diabetes Care 2001;24:1433-7.
48. A., A., Risk factors for diabetic neuropathy and foot ulceration. Curr Diab Rep. 2001
Dec;1(3):202-7.
49. Van, G.H., chapitre 4: la neuropathie diabétique Le pied diabétique édition 2008 pages
24-25-26-27.
50. P. Valensi, I.B., S. Chiheb, Neuropathie diabétique. Diabétologie 2014 Chapitre 12. page 262 51. Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes
therapy on the development and progression of neuropathy. Ann Intern Med 1995;122(8):561-8. .
52. Tesfaye S, C.N., Eaton SEM, Ward JD, Manes C, Ionescu-Tirgoviste C, et al., Vascular risk
factors and diabetic neuropathy. N Engl J Med 2005;352(4):341-50. .
53. Dyck PJ, D.J., Wilson DM, Service FJ, Melton LJ, O’Brien PC. , Risk factors for severity of
diabetic polyneuropathy: intensive longitudinal assessment of the Rochester diabetic neuropathy study cohort. Diabetes Care 1999;22(9):1479-86. .
Prise en charge du pied diabétique aux urgences
120
54. Eds., O.N.L.B.J., Neuropathy in the diabetic foot: new concepts in etiology and treatment.
Levin Me, The diabetic foot. St Louis: CV Mosby, 1993: 135-148.
55. AN., P., Diabetic polyneuropathy. Risk factors, patterns of presentation, diagnosis, and
treatment. Geriatrics 2003;58(6):16-30. .
56. Davies M, B.S., Williams R, Taylor A. , The prevalence, severity, and impact of painful
diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care 2006;29(7):1518-22. .
57. J., P., Diabète et complications dégénératives, présentation d’une étude prospective portant
sur 4400 cas observés entre 1947 et 1973.. Diabète Metab 1977 ; 3 : 97,107,245-246.
58. Gautier JF, C.B., Edan G, Balarac N, Halimi S, et al., Neuropathie diabétique périphérique.
Recommandations. Paris: Alfédiam; 1997. . Association de langue française pour l’étude du
diabète et des maladies métaboliques.
59. Santé, H.A.d., Recommandations professionnelles.Prise en charge diagnostique des
neuropathies périphériques (Polyneuropathies et mononeuropathies multiples). 2007.
60. Al-Mahroos F1, A.-R.K., Diabetic neuropathy, foot ulceration, peripheral vascular disease and
potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study.Ann Saudi Med. 2007 Jan-Feb;27(1):25-31.
61. Frykberg RG, Z.T., Armstrong DG, Driver VR, Giurini JM, Kravitz SR, Landsman AS, Lavery LA, Moore JC, Schuberth JM. , Diabetic foot disorders. A clinical practice guideline (2006 revision).
J Foot Ankle Surg. 2006;45:S1-66. .
62. Monteiro-Soares M, B.E., Ribeiro J, Ribeiro I, Dinis-Ribeiro M. , Predictive factors for diabetic
foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012;28:574-600. .
63. Shahbazian H, Y.L., Latifi SM. , Risk assessment of patients with diabetes for foot ulcers
according to risk classification consensus of International Working Group on Diabetic Foot (IWGDF). Pak J Med Sci. 2013;29:730-734.
64. Iraj B, K.F., Ebneshahidi A, Askari G. , Prevention of diabetic foot ulcer. Int J Prev Med.
2013;4:373-376.
65. Waaijman R, d.H.M., Arts ML, Wever D, Verlouw AJ, Nollet F, Bus SA. , Risk factors for
plantar foot ulcer recurrence in neuropathic diabetic patients. Diabetes Care. 2014;37:1697-1705.
66. McEwen LN, Y.K., Herman WH, Wrobel JS. , Prevalence and risk factors for diabetes-related foot complications in Translating Research Into Action for Diabetes (TRIAD). J Diabetes Complications. 2013;27:588-592.
Prise en charge du pied diabétique aux urgences
121
67. Lavery LA, A.D., Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. , Risk factors for foot
infections in individuals with diabetes. Diabetes Care 2006; 29:1288-93.
68. Peters EJ, L.L., Armstrong DG., Diabetic lower extremity infection: influence of physical,
psychological, and social factors. J Diabetes Complications 2005; 19:107-12.
69. Bartos V, J.A., Koznarova R. , [Risk factors for diabetic foot in recipients of renal and
pancreatic transplants]. Cas Lek Cesk 1997; 136:527-9.
70. Hill MN, F.H., Hilton SC, Holechek MJ, Ylitalo M, Benedict GW. , Risk of foot complications in
long-term diabetic patients with and without ESRD: a preliminary study. ANNA J 1996; 23:381-6; discussion 87-8.
71. Jayasinghe SA, A.I., Gunethilleke B, Siriwardena V, Herath SC, De Abrew K. , Is walking
barefoot a risk factor for diabetic foot disease in developing countries? Rural Remote Health 2007; 7:692.
72. J. M'Bemba, E.A., E.Larger, Le pied diabétique aux urgences. Le journal européen des
Urgences et de la réanimation (2014) 2,6 87-96.
73. AMJ., B., The pathway to foot ulceration in diabetes.Med Clin North Am 2013; 97:775-90. 74. Alavi A, S.R., Mayer D, Goodman L, Botros M, et al., Diabetic foot ulcers: part I. Pathologiy
and prevention. JAmcard Dermatol 2014; 70:1.e-1-18.
75. Boulton AJ, V.L., Ragnarson-Tennvall G, Apelqvist J. , The global burden of diabetic foot
disease. Lancet. 2005;366:1719-1724.
76. Alavi A, S.R., Mayer D, Goodman L, Botros M, et al., Diabetic foot ulcers part II. Managment.
J AmACad Dermatol 2014; 70:21. e 21-4.
77. Prompers L, H.M., Apelqvist J, et al. , High prevalence of ischaemia, infection and serious
comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 2007; 50:18-25.
78. Recommandations de Bonnes Pratiques : Prise en Charge des Plaies dans l' Ulcère du Pied Diabétique, Wounds International, 2013.
79. Debure, O.T.C., Pied diabétique . EMC (Elsivier Masson SAS, Paris), Dermatologe ,
Prise en charge du pied diabétique aux urgences
122
80. S Hannat, S.K., R Chermat, A Nechadi, R Malek, Lésions trophiques du pied diabétique. À
propos de 236 cas. Médecine Interne, Centre Hospitalier Universitaire de Setif, Algérie. ALFEDIAM 2008.
81. C., J., Le pied de Charcot ou l'Ostéo-arthopathie nerveuse diabétique. Soins (avril) 2007; 714
(suppl) S17-S19.
82. Cathy Journot, Le pied de Charcot l’ostéo-arthropathie nerveuse diabétique. Centre de
cicatrisatio, service de diabétologie, CHU Toulouse Rangueil.Soins complémentaire N°714-avril 2007, EMS.
83. Peters EJ, L.L., International Working Group on the Diabetic Foot. Effectiveness of the diabetic
foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care 2001;24:1442—7.
84. F. Bouilloud C. Sachon , A.H.-H., G. HA VAN, A. Grimaldi, Pied diabétique 2008.
85. Malgrange, R.D., Physiopathology of the diabetic foot Service de Médecine interne, CHU
Reims, 45 r Cognacq Jay 51100 Reims, France La revue de médecine interne 29 (2008) S231– S237.
86. Lipsky BA, B.A., Embil J, De Lalla F., Diagnosing and treating diabetic foot infections.
Diabetes Metab Res Rev 2004;20:S56–64.
87. Recommandations pour la pratique clinique. Prise en charge du pied diabétique infecté .Texte long.Medecine et maladies infectieuses 37 (2007) 26-50.
88. BA., L., Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997;25:1318-26.
89. Rajbhandari SM, S.M., Davies C, Tesfaye SS, Ward JD., "Saussage toe":a reliable sign of
underlying osteomyelitis. Diabet Med 2000;17:74-7.
90. K. Bertal Filali, A.E., A. Diouri, , Profil clinique, bactériologique et thérapeutique de l'infection
du pied diabétique. A propos de 31 cas. Endocrinologie Diabétologie Nutrition, CHU, Marrakech, Maroc 2009.
91. MA. Mahamane Sani, M.D., PK. Dago, S. Brah, Profil des patients présentant un pied
diabétique compliqué d’ostéite au service d’Endocrinologie Diabétologie du CHU de Yopougon (Côte d’Ivoire) SFD 2012
92. Benjamin A. Lipsky, A.R.B., Paul B. Cornia, James C. Pile, Edgar J. G. Peters, David G. Armstrong, et col., 2012 Infectious Diseases Society of America Clinical Practice Guideline for
Prise en charge du pied diabétique aux urgences
123
93. Karthikesalingam A, H.P., Moxey P, Jones KG, Thompson MM, and H. RJ.,A systematic
review of scoring systems for diabetic foot ulcers. Diabet Med 2010; 27:544-9. .
94. NC., S., Diabetic foot ulcer classification system for research purposes: a progress report on
criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20(Suppl 1):S90-5.
95. Lavery LA, A.D., Harkless LB. , Classification of diabetic foot wounds. J Foot Ankle Surg
1996;35:528-31.
96. Armstrong DG, L.L., Harkless LB. , Validation of a diabetic wound classification system. The
contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care 1998; 21:855-9.
97. Oyibo SO, J.E., Tarawneh I, et al. , A comparison of two diabetic foot ulcer classification
systems. Diabetes Care 2001; 24(1): 84-88.
98. Lavery LA, A.D., Murdoch DP, Peters EJ, Lipsky BA., Validation of the Infectious Diseases
Society of America’s diabetic foot infection classification system. Clin Infect Dis 2007; 44:562-5.
99. Cavanagh PR, L.B., Bradbury AW, Batek G., Treatment for diabetic foot ulcers. Lancet
2005;366:1725-35.
100. Wheat LJ, A.S., Henry M, et al. , Diabetic foot infections. Bacteriologic analysis. Arch Intern Med 1986;146:1935-40.
101. Pellizzer G, S.M., Presi S, et al. , Deep tissue biopsy vs. superficial swab culture monitoring in
the microbiological assessment of limb-threatening diabetic foot infection. Diabet Med 2001;18:822-7.
102. Adil Zemmouri, M.T., Abdellatif Benbouha, Tarik Lamkinsi, Mustapha Bensghir, Mostafa Elouennass, Cherqui Haimeur, Profil bactériologique du pied diabétique et son impact sur le
choix des antibiotiques. Service de Réanimation-Anesthésie de l'HMIMV. Pan African Medical Journal. 2015; 20:148 doi:10.11604/pamj.2015.20.148.5853 This article is available online at: http://www.panafrican-med-journal.com/content/article/20/148/full/.
103. F Desbiez , O.L., I Tauveron Culture de prélèvements osseux obtenus via la plaie : une
procédure simplifiée pour le traitement médical des infections ostéo-articulaires (IOA) du pied diabétique Endocrinologie, CHU et Université d’Auvergne, Clermont-Ferrand ; Service de Maladies Infectieuses et Tropicales, CHU et Université d’Auvergne,Clermont-Ferrand.
104. S Hannat, F.S., S Khettabi, R Chermat, FZ Mekideche, R. Malek., Profil bactériologique des
lésions trophiques du pied diabétique et leur résistance aux antibiotiques. Médecine Interne, Centre Hospitalier Universitaire de Setif, Setif, Algérie.
Prise en charge du pied diabétique aux urgences
124
105. Eneroth M, A.J., Stenstrom A. , Clinical characteristics and outcome in 223 diabetic patients
with deep foot infections. Foot Ankle Int 1997;18:716-22.
106. Armstrong DG, L.L., Sariaya M, Ashry H. , Leukocytosis is a poor indicator of acute
osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg 1996;35:280-3.
107. Edmonds ME, F.A., Sanders LJ., A practical manual of diabetic foot care. Oxford: Blackwell
Publishing Ltd. 2004:102-40.
108. Jeandrot A, R.J., Combescure C, et al. , Serum procalcitonin and C-reactive protein
concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 2008; 51:347–52.
109. Uzun G, S.E., Curuksulu H, et al. , Procalcitonin as a diagnostic aid in diabetic foot infections.
Tohoku J Exp Med 2007;213:305-12.
110. Charles Pierret, J.-P.T., Lise Bordier, Emmanuel Blin, Vincent Duverger, Revascularisation du
pied diabétique Presse Med. 2011; 40: 10–16 2010 Elsevier Masson SAS.
111. Mesure de la pression systolique du gros orteil,
http://www.atysmedical.fr/media/montage_pied_3_15.jpg.
112. Chantelau E, T.T., Altenhofer F, Ersanli Z, Lacigova S, Metzger C., Antibiotic treatment for
uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial. Diabet Med 1996;13:156–9.
113. Abbas M, U.I., Lipsky BA., In diabetic foot infections antibiotics are to treat infection, not to
heal wounds.Expert Opin Pharmacother. 2015 Apr;16(6):821-32.2015 Mar 3.
114. Edmonds M, F.A., The use of antibiotics in the diabetic foot. Am J Surg 2004;187:S25-S8. 115. BA., C., Antibiotic selection for diabetic foot infections: a review. J Foot Ankle Surg
2000;39:25-37.
116. BA., L., Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med
Microbiol 1999;26:267-76.
117. Hartemann-Heurtier A, M.L., Ha Van G, Grimaldi A., Place de l'antibiothérapie dans le
traitement du pied diabétique. Diabetes Metab 2000;26:219-24.
118. NASSER, I.I.M., antibiothérapie des infections du pied diabétique. 2013.
119. Seabrook GR, E.C., Schmitt DD, Krepel C, Bandyk DF, Towne JB., Comparison of serum and
Prise en charge du pied diabétique aux urgences
125
120. PG., C., Clinical efficacy, tolerability, and cost savings associated with the use of open-label
metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lowerextremity infections in older males. Am J Geriatr Pharmacother 2004;2:181-9.
121. Lipsky BA, I.K., Norden C. , Treating foot infections in diabetic patients: a randomized,
multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis 2004;38:17- 24.
122. Couret G, D.F., Thieblot P, et al. , Emergence des infections monomicrobiennes à
staphylocoque doré méticilline-résistant dans les ostéites du pied diabétique. Presse Med 2007;36:851-8.
123. Omar NS, E.-N.M., Gray J., Novel antibiotics for the management of diabetic foot infections.
Int J Antimicrob Agents 2008;31:411-9.
124. Ha Van, G., Artériopathie Diabétique des Membres Inférieurs. 2008: p. 30-45.
125. BA., L., Medical treatment of diabetic foot infections. Clin Infect Dis 2004;39:S104-14.
126. A. Toumi , L.B., M. Chakroun , ANTIBIOTIC THERAPY FOR DIABETIC FOOT INFECTIONS Revue Tunisienne d’Infectiologie. Avril 2011, Vol.5, N°2 : 61 - 67.
127. Haddoun Ar., W.A., Zryouil B., Rafai M., Le pied diabétique. Espérance médicale 2004, 11,
108 :441-446.
128. P., C., Advances in the treatment of the diabetic foot: Is there a role for adjunctive hyperbaric
oxygen therapy? Wound Rep Reg 2004;12:2-10.
129. Kranke P, B.M., Roeckl-Wiedmann I, Debus S., Hyperbaric oxygen therapy for chronic
wounds. Cochrane Database Syst Rev 2005;2:CD004123.
130. M ., L., Hyperbaric oxygen therapy as adjunctive treatment of diabetic foot ulcers. Med Clin
North Am. 2013 Sep;97(5):957-80. doi: 10.1016/j.mcna.2013.04.004. Epub 2013 Jul 6.
131. Ha Van G, S.H., Hartemann-Heurtier A, Jacqueminet S, Greau F, GrimaldiA. , Nonremovable,
windowed, fiberglass cast boot in the treatment of diabetic plantar ulcers: efficacy, safety, and compliance. Diabetes Care 2003;26:2848-52.
132. Waniczek D1, K.A., Muc-Wierzgoń M, Kokot T, Swiętochowska E, Nowakowska-Zajdel E.,
Adjunct methods of the standard diabetic foot ulceration therapy.Evid Based Complement Alternat Med. 2013;2013:243568. doi: 10.1155/2013/243568. Epub 2013 Jun 13.
Prise en charge du pied diabétique aux urgences
126
133. Stoekenbroek RM1, S.T., Koelemay MJ, van Hulst RA, Legemate DA, Reekers JA, Ubbink DT., Is additional hyperbaric oxygen therapy cost-effective for treating ischemic diabetic
ulcers? Study protocol for the Dutch DAMOCLES multicenter randomized clinical trial?J Diabetes. 2015 Jan;7(1):125-32. doi: 10.1111/1753-0407.12155. Epub 2014 Apr 28.
134. O'Reilly D1, P.A., Campbell K, Burke N, Assasi N, Bowen JM, Tarride JE, Goeree R.,
Hyperbaric oxygen therapy for diabetic ulcers: systematic review and meta-analysis. Int J Technol Assess Health Care. 2013 Jul;29(3):269-81. doi: 10.1017/S0266462313000263.
135. Krankel N, A.V., Linke A et al., Hyperglycemia reduces survival and impairs function of
circulating bloodderived progenitor cells. Arterioscler Thromb Vasc Biol 2005;25:698- 703.
136. Jeffcoate WJ, P.P., Harding KG. , Wound healing and treatments for people with diabetic foot
ulcers. Diabetes Metab Res Rev 2004;20:S78-89.
137. Van den Berghe G, W.A., Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaerts H, Bouillon RN. , Intensive insulin therapy in the medical ICU. N
Engl J Med 2006;354:449-61.
138. Weringer EJ, K.J., Tamai IY, Arquilla ER., The effect of antisera to insulin,
2-deoxyglucose-induced hyperglycemia, and starvation on wound healing in normal mice. Diabetes 1981;30:407-10.
139. Langouche L, V.I., Vlasselaers D, et al. , Intensive insulin therapy protects the endothelium of
critically ill patients. J Clin Invest 2005;115: 2277-86.
140. Mueller MJ, D.J., Sinacore DR, et al. , Total contact casting in treatmentof diabetic plantar
ulcers. Controlled clinical trial. Diabetes Care 1989;12:384-8.
141. Armstrong DG, N.H., Lavery LA, van Schie CH, Boulton AJ, Harkless LB. Off-loading the
diabetic foot wound: a randomized clinical trial. Diabetes Care 2001;24:1019-22.
142. Armstrong DG, L.L., Wu S, Boulton AJ. , Evaluation of removable and irremovable cast
walkers in the healing of diabetic foot wounds: a randomized controlled trial. Diabetes Care 2005;28:551-4.
143. Caravaggi C, F.E., De Giglio R, et al. , Effectiveness and safety of a nonremovable fiberglass
off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomized study. Diabetes Care 2000;23:1746-51.
144. Dumont, I., Décharge:Objectifs et méthodes. Labotte de Ransart. 27-076-A-35 .EMC 2014 145. Armstrong DG, L.L., Evidence-based options for off-loading diabetic wounds. Clin Podiatr Med
Prise en charge du pied diabétique aux urgences
127
146. Katz IA, H.A., Miranda-Palma B, et al. , A randomized trial of two irremovable off-loading
devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005;28:555-9.
147. GP., G., An analysis of iatrogenic complications from the total contact cast. Foot Ankle Int
2005;26:903-7.
148. Chantelau E, B.U., Leisch AC, Tanudjaja T, Reuter M. , Outpatient treatment of unilateral
diabetic foot ulcers with "half shoes". Diabet Med 1993;10:267-70.
149. Katz IA, H.A., Miranda-Palma B, Prieto-Sanchez L, Armstrong DG, Bowker JH, et al. , A
randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005;28:555-9.
150. Caravaggi C, F.E., De Giglio R, et al. , Effectiveness and safety of a nonremovable fiberglass
off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a